US FDA gives EUA for Pfizer/BioNTech COVID-19 vaccine Reuters Dec 12, 2020 The first inoculations would happen early next week
FDA Advisory Committee supports EUA of Pfizer-BioNTech COVID-19 vaccine in US EP News Bureau Dec 11, 2020 FDA Advisory Committees provide non-binding recommendations, with the final decision on approval or authorisation to be made by…
MHRA issues anaphylaxis warning for Pfizer BioNTech vaccine Reuters Dec 10, 2020 Pfizer and BioNTech said they were supporting the MHRA’s investigation
US FDA staff back Pfizer COVID-19 vaccine data, authorisation likely soon Reuters Dec 9, 2020 Data from the trial showed that the vaccine began conferring some protection to recipients even before they received the second…
UK commences roll-out of Pfizer’s COVID-19 vaccine Reuters Dec 8, 2020 Britain approved the vaccine for emergency use less than a week ago, and is rolling it out through its National Health Service…
Pfizer-BioNTech can use UK as test bed for cold chain distribution: GlobalData EP News Bureau Dec 3, 2020 The country’s small size, dense population and strong healthcare infrastructure should mean distribution of the vaccine with cold…
Evaluating Pfizer vaccine for possible listing for emergency use: WHO Reuters Dec 2, 2020 WHO is in discussions with MHRA for accessing some of the information from their assessment which may expedite WHO’s emergency…
Pfizer-BioNTech COVID-19 vaccine gets EUA approval from the UK Reuters Dec 2, 2020 Care home residents, health and care staff, the elderly and people who are clinically extremely vulnerable will be first in line
Britain may approve COVID-19 vaccine from Pfizer-BioNTech this week, reports Telegraph Reuters Nov 23, 2020 The report also informs that the NHS had been told to be ready to administer it by December 1
Pfizer-BioNTech COVID-19 vaccine may create set of firsts for pharma sector: GlobalData EP News Bureau Nov 21, 2020 In modern history, no vaccine has ever been considered as essential to restoring normality to our way of life as these first mRNA…